Sources of confounding in life course epidemiology.


Journal

Journal of developmental origins of health and disease
ISSN: 2040-1752
Titre abrégé: J Dev Orig Health Dis
Pays: England
ID NLM: 101517692

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 17 8 2018
medline: 20 6 2020
entrez: 17 8 2018
Statut: ppublish

Résumé

In epidemiologic analytical studies, the primary goal is to obtain a valid and precise estimate of the effect of the exposure of interest on a given outcome in the population under study. A crucial source of violation of the internal validity of a study involves bias arising from confounding, which is always a challenge in observational research, including life course epidemiology. The increasingly popular approach of meta-analyzing individual participant data from several observational studies also brings up to discussion the problem of confounding when combining data from different populations. In this study, we review and discuss the most common sources of confounding in life course epidemiology: (i) confounding by indication, (ii) impact of baseline selection on confounding, (iii) time-varying confounding and (iv) mediator-outcome confounding. We also discuss the issue of addressing confounding in the context of an individual participant data meta-analysis.

Identifiants

pubmed: 30111382
pii: S2040174418000582
doi: 10.1017/S2040174418000582
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-305

Auteurs

S Santos (S)

1The Generation R Study Group,Erasmus MC, University Medical Center,Rotterdam,The Netherlands.

D Zugna (D)

3Department of Medical Sciences,Cancer Epidemiology Unit,University of Turin and CPO-Piemonte,Turin,Italy.

C Pizzi (C)

3Department of Medical Sciences,Cancer Epidemiology Unit,University of Turin and CPO-Piemonte,Turin,Italy.

L Richiardi (L)

3Department of Medical Sciences,Cancer Epidemiology Unit,University of Turin and CPO-Piemonte,Turin,Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH